跳至主要内容
临床试验/NCT05662267
NCT05662267已完成不适用

Targeted Trial Emulation of Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Transplant Recipients : a French Nationwide Cohort Study

University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 327 人开始时间: 2020年3月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
327
试验地点
1
主要终点
Patient-graft survival

研究概览

简要总结

Islet transplantation is associated with a benefit on glycaemic control compared to optimized insulin therapy in recent clinical trials. However, there is a lack of evidence concerning the long-term impact of islet transplantation on type 1 diabetic kidney transplant recipients' prognosis. The objective of the study is to assess the impact of islet transplantation in patients with type 1 diabetes and a kidney transplantation on the risk of graft failure. Every type 1 diabetic recipient transplanted with a kidney in France between 2000 and 2017 is included. Patients transplanted with pancreatic islets are compared to controls treated with insulin alone according to a matching method based on time-dependent propensity scores which allow to ensure patients comparability at the time of islet transplantation. Time-dependent propensity scores are built according to variables associated with both the probabilities of being transplanted with islets and the outcome of interest. These variables are assessed by a direct acyclic graph. The primary outcome consists in death-uncensored graft survival, defined by death or return to dialysis. Secondary outcomes include the risk of death, or the risk of death-censored graft survival.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient is aged over 18
  • •With type 1 diabetes
  • •With End-Stage Renal disease
  • •Transplanted with a kidney
  • •Between 2000 and 2017

排除标准

  • •Patients with type 2 diabetes
  • •Patients with a previous pancreatic transplantation with a pancreatic graft functioning at the time of kidney transplantation.

研究组 & 干预措施

Islet-after-kidney group

Patients with type 1 diabetes with a kidney transplant received or not an islet transplantation after kidney transplantation. As soon as they received an islet transplantation, they belong to the "Islet-after-kidney group".

Kidney alone group

Patients with type 1 diabetes with a kidney transplant who did not receive an islet transplantation belong to the " Kidney alone group ".

干预措施: Pancreatic islet transplantation after kidney transplantation (Other)

结局指标

主要结局

Patient-graft survival

时间窗: From the date of islet transplantation (or time-point equivalent in the control group) until the date of death from any cause or return to dialysis, whichever comes first, assessed up to 240 months.

Patient-graft survival by death-uncensored graft survival, i.e. the return to dialysis or death

次要结局

  • Patient survival(From the date of islet transplantation (or time-point equivalent in the control group) until the date of death from any cause, assessed up to 240 months)
  • Death-censored graft survival(From the date of islet transplantation (or time-point equivalent in the control group) until the date of death from any cause, assessed up to 240 months)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验